Bizz Buzz Bureau Hyderabad

City-based Pulse Pharmaceuticals has reached a major milestone with the regulatory approval of its Nano-Carrier Entrapped Vitamin D3 Oral Dispersion. This approval transforms advanced nano pharmaceutical research into a regulated, patient-ready product. After strict scientific evaluation, Pulse Pharmaceuticals achieved regulatory approval for its pioneering nanocarrier technology in Vitamin D3 delivery, such an approval is probably first in the world. Clinical studies have demonstrated 50-60 per cent higher serum vitamin D levels with Nano-carrier entrapped Vitamin D3 Oral Dispersion compared to conventional formulations. The company has been working in nano pharmaceutical drug delivery since 2010, aiming to solve real-world challenges for large patient populations.

Their proprietary "Aqueol" platform technology is specifically designed to effectively deliver lipophilic compounds in water-based mediums.

Better Performance and Convenience: Pulse uses nanotechnology to improve how well a drug works, its bioavailability, how easily it is tolerated, and the overall patient experience.